Meeting Report

Treating Venous Thrombosis in Oncology

Presented by Rowena Schwartz, PharmD, BCOP

University of Cincinnati, Cincinnati, Ohio

Presenter’s disclosures of conflicts of interest are found at the end of this article.


J Adv Pract Oncol 2019;10(3):230–232 | https://doi.org/10.6004/jadpro.2019.10.3.5 | © 2019 Harborside™


  

ABSTRACT

According to Rowena Schwartz, PharmD, BCOP, it is important to consider broad treatment options, both direct oral anticoagulants and older agents such as heparin, when treating patients with venous thromboembolism, as the newer agents may not be for everyone. Dr. Schwartz also reviewed how to monitor and assess patient response to anticoagulant treatment.




For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2019 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.